跳至主要内容
临床试验/NCT05634655
NCT05634655招募中不适用

Dissecting the Mechanism of DNA Methylation on the Invasiveness of Pituitary

Second Affiliated Hospital, School of Medicine, Zhejiang University1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2022年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
500
试验地点
1
主要终点
Residual tumor size

研究概览

简要总结

DNA methylation is one of the important ways of protein post-translational modification.Pituitary adenoma (PA) is a benign neuroendocrine tumor that originates from adenohypophysial 45 cells, and accounts for 10%-20% of all primary intracranial tumors. However some PAs can present with high invasiveness and irregular growth, which tend to compresses the optic chiasm and third ventricle, encase the internal carotid artery, and affect hormone secretion from the pituitary gland and hypothalamus. In this study we focus on the mechanism of DNA methylation on the invasiveness of pituitary tumors.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • histologically confirmed PAs, 2) Non-function pituitary adenomas

排除标准

  • Associated with other tumors or serious underlying diseases, 2) the medical records were not complete, or the follow-up data were missing.

结局指标

主要结局

Residual tumor size

时间窗: 1 week after surgery

Tumor size was evaluated by postoperative MRI

tumor recurrence

时间窗: three years

During the follow-up, the tumor recurrence was observed closely

次要结局

未报告次要终点

研究者

发起方
Second Affiliated Hospital, School of Medicine, Zhejiang University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验